FrancophonIA/ELRC3.0 huggingface dataset:
English: No dose adjustment required for raltegravir or methadone.
Danish: Dosisjustering af raltegravir eller methadon er ikke nødvendig.
English: Tablet core - Microcrystalline cellulose - Lactose monohydrate - Calcium phosphate dibasic anhydrous - Hypromellose 2208 - Poloxamer 407 - Sodium stearyl fumarate - Magnesium stearate
Danish: Tabletkerne - Mikrokrystallinsk cellulose - Lactosemonohydrat - Calciumphosphat, dibasisk, vandfrit - Hypromellose 2208 - Poloxamer 407 - Natriumstearylfumarat - Magnesiumstearat
English: BENCHMRK 1 and BENCHMRK 2 (multi-centre, randomised, double-blind, placebo-controlled trials) evaluated the safety and anti-retroviral activity of raltegravir 400 mg twice daily vs. placebo in a combination with optimised background therapy (OBT), in HIV-infected patients, 16 years or older, with documented resistance to at least 1 drug in each of 3 classes (NRTIs, NNRTIs, PIs) of anti-retroviral therapies.
Danish: BENCHMRK 1 og BENCHMRK 2 (randomiserede, dobbeltblindede, placebokontrollerede multicenterstudier) vurderede sikkerheden og den antiretrovirale aktivitet af raltegravir 400 mg to gange dagligt versus placebo i en kombination med OBT hos hiv-inficerede patienter, i alderen 16 år og ældre, der har dokumenteret resistens over for mindst ét lægemiddel i hver af de 3 klasser (NRTIere, NNRTIere, PIere) af antiretroviral terapi.
English: Raltegravir has been studied in 126 antiretroviral treatment-experienced HIV-1 infected children and adolescents 2 to 18 years of age, in combination with other antiretroviral agents in IMPAACT P1066 (see sections 5.1 and 5.2).
Danish: Raltegravir er blevet undersøgt hos 126 antiretrovirale behandlingserfarne hiv-1-inficerede børn og unge i alderen 2 til 18 år i kombination med andre antiretrovirale lægemidler i IMPAACT P1066 (se pkt.
English: For analysis by prognostic factors, virologic failures were carried forward for percent < 50 and 400 copies/mL.
Danish: Ved den prognostiske analyse blev virologisk svigt analyseret som "carry forward" for procent med henholdsvis < 50 og 400 kopier/ml.
English: Therefore, co-administration of raltegravir with aluminium and/or magnesium containing antacids is not recommended.
Danish: Administration af raltegravir sammen med aluminium- og/eller magnesiumholdige antacida frarådes derfor.
English: METAL CATION ANTACIDS aluminium and magnesium hydroxide antacid (raltegravir 400 mg Twice Daily)
Danish: ANTACIDA INDEHOLDENDE METALKATIONER antacidum med aluminium- og magnesiumhydroxid (raltegravir 400 mg to gange dagligt)
English: 11 to less than 25 kg Chewable tablet
Danish: 11 til under 25 kg
English: Infants and toddlers 4 weeks to less than 2 years of age Raltegravir twice daily has also been studied in 26 HIV-1 infected infants and toddlers 4 weeks to less than 2 years of age, in combination with other antiretroviral agents in IMPAACT P1066 (see sections 5.1 and 5.2).
Danish: Spædbørn og småbørn i alderen 4 uger til under 2 år Raltegravir to gange dagligt er også blevet undersøgt hos 26 hiv-1-inficerede spædbørn og småbørn i alderen 4 uger til under 2 år i kombination med andre antiretrovirale midler i IMPAACT P1066 (se pkt.
English: ISENTRESS is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection (see sections 4.2, 4.4, 5.1 and 5.2).
Danish: ISENTRESS er, i kombination med andre antiretrovirale lægemidler, indiceret til behandling af infektion med humant immundefekt-virus (hiv-1) (se pkt.
English: Carton for ISENTRESS 100 mg granules for oral suspension
Danish: Karton til ISENTRESS 100 mg granulat til oral suspension
English: Skin problems
Danish: Hudproblemer
English: Raltegravir AUC and Cmax increase dose proportionally over the dose range 100 mg to 1,600 mg. Raltegravir C12 hr increases dose proportionally over the dose range of 100 to 800 mg and increases slightly less than dose proportionally over the dose range 100 mg to 1,600 mg.
Danish: I dosisintervallet 100 mg-800 mg øgede raltegravir C12t proportionalt med dosis, men dosisproportionaliteten var lidt mindre end for dosisintervallet 100 mg-1.600 mg.
English: Refer to the 600 mg tablet SmPCs for additional dosing information.
Danish: Se produktresuméet for 600 mg tabletten for yderligere oplysninger om dosering.
English: • bloating; abdominal pain; diarrhoea; excessive gas in the stomach or bowel; feeling sick;
Danish: • Oppustethed, mavesmerter, diarré, usædvanlig meget luft i mave eller tarme, kvalme,
English: Weight based dosing, see dosing Table 2 13
Danish: Vægtbaseret dosering, se doseringstabellerne for tyggetabletten 13
English: Achieved HIV RNA <50 copies/mL Mean CD4 cell count (%) increase from baseline
Danish: Opnået hiv-RNA <50 kopier/ml Gennemsnitligt CD4-celletal (%) stigning ift.
English: What Isentress contains
Danish: Isentress indeholder:
English: • joint pain; painful joint disease; back pain; pain in bone/muscle; muscle tenderness or weakness; neck pain; pain in arms or legs; inflammation of the tendons; decrease in the amount of minerals in the bone
Danish: • Ledsmerter, smertefuld ledsygdom, rygsmerter, smerter i knogler/muskler, muskelømhed ellersvaghed, nakkesmerter, smerter i arme og/eller ben, senebetændelse, fald i knoglemineraler
English: Treatment-naïve adult patients (1,200 mg [2 x 600 mg] once daily) ONCEMRK (multi-centre, randomised, double-blind, active-control trial; Protocol 292) evaluated the safety and anti-retroviral activity of raltegravir 1,200 mg once daily + emtricitabine (+) tenofovir disoproxil fumarate vs. raltegravir 400 mg twice daily, in combination with emtricitabine (+) tenofovir disoproxil fumarate, in treatment-naïve HIV-infected patients with HIV RNA > 1,000 copies/mL.
Danish: Behandlingsnaive voksne patienter (1.200 mg [2 x 600 mg] en gang dagligt) ONCEMRK (randomiseret, dobbeltblindet, aktivt kontrolleret multicenterstudie; Protokol 292) vurderede sikkerhed og antiretroviral aktivitet af raltegravir 1.200 mg en gang dagligt + emtricitabin (+) tenofovirdisoproxilfumarat versus raltegravir 400 mg to gange dagligt i kombination med emtricitabin (+) tenofovirdisoproxilfumarat hos behandlingsnaive hiv-inficerede patienter med hivRNA > 1.000 kopier/ml.
English: Uncommon anaemia, iron deficiency anaemia, lymph node pain, lymphadenopathy, neutropenia, thrombocytopenia
Danish: Blod og lymfesystem Ikke almindelig Anæmi, jernmangelanæmi, smerter i lymfeknuder, lymfadenopati, neutropeni, trombocytopeni
English: The other ingredients are: lactose monohydrate, microcrystalline cellulose, calcium phosphate dibasic anhydrous, hypromellose 2208, poloxamer 407, sodium stearyl fumarate, and magnesium stearate.
Danish: Øvrige indholdsstoffer: lactosemonohydrat; mikrokrystallinsk cellulose; calciumphosphat, dibasisk, vandfrit; hypromellose 2208; poloxamer 407; natriumstearylfumarat og magnesiumstearat.
English: Infants and toddlers 4 weeks to less than 2 years of age Raltegravir has also been studied in 26 HIV-1 infected infants and toddlers 4 weeks to less than 2 years of age, in combination with other antiretroviral agents in IMPAACT P1066 (see sections 5.1 and 5.2).
Danish: Spædbørn og småbørn i alderen 4 uger til under 2 år Raltegravir er også blevet undersøgt hos 26 hiv-1-inficerede spædbørn og småbørn i alderen 4 uger til under 2 år i kombination med andre antiretrovirale midler i IMPAACT P1066 (se pkt.
English: The orange-banana flavoured chewable tablet is oval-shaped, pale orange coloured, scored on both sides with the MSD corporate logo and "477" on one side and without inscription on the other side.
Danish: Tyggetabletten med appelsin-banansmag er oval, lys orange, med delekærv på begge sider, og mærket med MSD-virksomhedslogo og "477" på den ene side og ingen mærkning på den anden side.
English: SEDATIVE midazolam (raltegravir 400 mg Twice Daily)
Danish: SEDATIVA midazolam (raltegravir 400 mg to gange dagligt)
English: • feeling dizzy; headache
Danish: • Svimmelhed, hovedpine
English: The evidence of efficacy of raltegravir was based on the analyses of 96-week data from two randomised, double-blind, placebo-controlled trials (BENCHMRK 1 and BENCHMRK 2, Protocols 018 and 019) in antiretroviral treatment-experienced HIV-1 infected adult patients, the analysis of 240-week data from randomised, double-blind, active-control trial (STARTMRK, Protocol 021) in antiretroviral treatment-naïve HIV-1 infected adult patients and the analysis of 96-week data from randomised, double-blind, active-control trial (ONCEMRK, Protocol 292) in antiretroviral treatment-naïve HIV-1 infected adult patients.
Danish: Evidens for klinisk virkning af raltegravir blev baseret på analyserne af 96-ugers data fra to randomiserede, dobbeltblindede, placebokontrollerede studier (BENCHMRK 1 og BENCHMRK 2, Protokol 018 og 019) hos antiretrovirale behandlingserfarne hiv-1 inficerede voksne patienter, analysen fra 240-ugers data fra et randomiseret, dobbeltblindet, aktivt kontrolleret studie (STARTMRK, Protokol 021) hos antiretrovirale behandlingsnaive hiv-1 inficerede voksne patienter og analysen af 96-ugers data fra et randomiseret, dobbeltblindet, aktivt kontrolleret studie (ONCEMRK, Protokol 292) hos antiretrovirale behandlingsnaive hiv-1 inficerede voksne patienter.
English: Raltegravir twice daily has been studied in 126 antiretroviral treatment-experienced HIV-1 infected children and adolescents 2 to 18 years of age, in combination with other antiretroviral agents in IMPAACT P1066 (see sections 5.1 and 5.2).
Danish: Raltegravir to gange dagligt er blevet undersøgt hos 126 antiretrovirale behandlingserfarne hiv-1inficerede børn og unge i alderen 2 til 18 år i kombination med andre antiretrovirale lægemidler i IMPAACT P1066 (se pkt.
English: • chest discomfort; chills; swelling of face; feeling jittery; generally feeling unwell; neck mass; swelling of hands, ankles or feet; pain
Danish: • Gener i brystet, kuldegysninger, hævelser i ansigtet, anspændthed, generel utilpashed, hævet hals, hævede hænder, ankler eller fødder, smerter
English: The evidence of efficacy of raltegravir was based on the analyses of 96-week data from two randomised, double-blind, placebo-controlled trials (BENCHMRK 1 and BENCHMRK 2, Protocols 018 and 019) in antiretroviral treatment-experienced HIV-1 infected adult patients and the analysis of 240-week data from a randomised, double-blind, active-control trial (STARTMRK, Protocol 021) in antiretroviral treatment-naïve HIV-1 infected adult patients.
Danish: Evidens for klinisk effekt af raltegravir blev baseret på analyserne af 96-ugers data fra to randomiserede, dobbeltblindede, placebokontrollerede studier (BENCHMRK 1 og BENCHMRK 2, Protokol 018 og 019) hos antiretrovirale behandlingserfarne hiv-1 inficerede voksne patienter samt analysen fra 240-ugers data fra et randomiseret, dobbeltblindet, aktivt kontrolleret studie (STARTMRK, Protokol 021) hos antiretrovirale behandlingsnaive hiv-1 inficerede voksne patienter.
English: 1.5 x 100 mg twice daily *The weight-based dosing recommendation for the chewable tablet, and oral suspension in 10mL of water is based on approximately 6 mg/kg/dose twice daily (see section 5.2).
Danish: * Den vægtbaserede doseringsanbefaling for tyggetabletten og den orale suspension i 10 ml vand er baseret på ca. 6 mg/kg/dosis to gange dagligt (se pkt.
English: Treatment-experienced adult patients (400 mg twice daily) BENCHMRK 1 and BENCHMRK 2 (multi-centre, randomised, double-blind, placebo-controlled trials) evaluated the safety and anti-retroviral activity of raltegravir 400 mg twice daily vs. placebo in a combination with optimised background therapy (OBT), in HIV-infected patients, 16 years or older, with documented resistance to at least 1 drug in each of 3 classes (NRTIs, NNRTIs, PIs) of anti-retroviral therapies.
Danish: Behandlingserfarne voksne patienter (400 mg to gange dagligt) BENCHMRK 1 og BENCHMRK 2 (randomiserede, dobbeltblindede, placebokontrollerede multicenterstudier) vurderede sikkerheden og den antiretrovirale aktivitet af raltegravir 400 mg to gange dagligt versus placebo i en kombination med OBT hos hiv-inficerede patienter, i alderen 16 år og ældre, der har dokumenteret resistens over for mindst ét lægemiddel i hver af de 3 klasser (NRTIere, NNRTIere, PIere) af antiretroviral terapi.
English: No dosage adjustment required for raltegravir or midazolam.
Danish: Dosisjustering af raltegravir eller midazolam er ikke nødvendig.
English: Results 48-week and 96-week analyses
Danish: Resultater af uge 48- og 96-analyser
English: Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Danish: Fortæl det altid til lægen eller apotekspersonalet, hvis du tager anden medicin eller har gjort det for nylig.
English: Chewable tablet 100 mg
Danish: Tyggetablet 100 mg
English: No dose adjustment required for raltegravir or etravirine.
Danish: Dosisjustering af raltegravir eller etravirin er ikke nødvendig.
English: Co-administration of raltegravir with aluminium and/or magnesium antacids is not recommended (see section 4.5).
Danish: Samtidig administration af raltegravir og aluminiumog/eller magnesiumholdige antacida frarådes (se pkt.
English: STARTMRK (multi-centre, randomised, double-blind, active-control trial) evaluated the safety and anti-retroviral activity of raltegravir 400 mg twice daily vs. efavirenz 600 mg at bedtime, in a combination with emtricitabine (+) tenofovir disoproxil fumarate, in treatment-naïve HIV-infected patients with HIV RNA > 5,000 copies/mL.
Danish: STARTMRK (randomiseret, dobbeltblindet, aktivt kontrolleret multicenterstudie) vurderede sikkerhed og antiretroviral aktivitet af raltegravir 400 mg to gange dagligt versus efavirenz 600 mg ved sengetid i en kombination med emtricitabin (+) tenofovirdisoproxilfumarat hos behandlingsnaive hiv-inficerede patienter med hiv-RNA >5.000 kopier/ml.
English: 2 x 100 mg twice daily
Danish: 2 x 100 mg to gange dagligt
English: How to take Isentress
Danish: Sådan skal du tage Isentress
English: The orange-banana flavoured chewable tablet is round and pale yellow, marked with the MSD corporate logo on one side and “473” on the other side.
Danish: Tyggetabletten med appelsin-banansmag er rund, lysegul, mærket med MSD-virksomhedslogo og "473" på den anden side.
English: ISENTRESS 25 mg chewable tablets ISENTRESS 100 mg chewable tablets
Danish: ISENTRESS 25 mg tyggetabletter ISENTRESS 100 mg tyggetabletter.
English: Carton for 400 mg film-coated tablets
Danish: Karton til 400 mg filmovertrukne tabletter
English: ), median [range] CD4 percent, median [range] HIV-1 RNA >100,000 copies/mL CDC HIV category B or C Prior ART Use by Class NNRTI NRTI PI
Danish: ), median [interval] CD4-procent, median [interval] Hiv-1 RNA >100.000 kopier/ml CDC hiv-kategori B eller C Tidligere antiretroviral behandling iht.
English: Rhabdomyolysis was an uncommonly reported serious adverse reaction in post-marketing use of raltegravir 400 mg twice daily.
Danish: Bivirkningen rabdomyolyse blev rapporteret med hyppigheden ikke almindelig i forbindelse med brug af raltegravir 400 mg to gange dagligt efter markedsføring.
English: Switch to raltegravir (400 mg twice daily)
Danish: Skift til raltegravir (400 mg to gange dagligt)
English: Bottle for ISENTRESS 600 mg film-coated tablets
Danish: Flaske til ISENTRESS 600 mg filmovertrukne tabletter
English: For analysis by prognostic factors, virologic failures were carried forward for percent < 400 and 50 copies/mL.
Danish: Ved den prognostiske analyse blev virologisk svigt analyseret som "carry forward" for procent med henholdsvis < 400 og ≤ 50 kopier/ml.
English: Nucleoside/tide reverse transcriptase inhibitors tenofovir disoproxil fumarate (raltegravir 400 mg Twice Daily)
Danish: Nukleoside/tide reverse transkriptasehæmmere tenofovirdisoproxilfumarat (raltegravir 400 mg to gange dagligt)
English: Aluminium and magnesium containing antacids reduce raltegravir plasma levels.
Danish: Antacida med aluminium og magnesium nedsætter raltegravirs plasmakoncentration.
English: What Isentress looks like and contents of the pack The 600 mg film-coated tablet is oval-shaped, yellow, marked with MSD corporate logo and "242" on one side and plain on the other side.
Danish: Den filmovertrukne 600 mg tablet er oval, gul, med MSD-virksomhedslogo og "242" præget på den ene side og uden prægning på den anden side.
English: Co-administration of raltegravir with aluminium and/or magnesium containing antacids is not recommended.
Danish: Administration af raltegravir sammen med aluminiumog/eller magnesiumholdige antacida frarådes.
English: • herpes infections including shingles
Danish: • Herpesinfektion, fx helvedesild
English: Unit dose sachet for ISENTRESS 100 mg granules for oral suspension - foil sachet
Danish: Enkeltdosisfoliepose til ISENTRESS 100 mg granulat til oral suspension - foliepose
English: Carton for 600 mg film-coated tablets
Danish: Karton til 600 mg filmovertrukne tabletter
English: raltegravir AUC  67% raltegravir C24hr  26% raltegravir Cmax  16%
Danish: raltegravir AUC  67% raltegravir C24t  26% raltegravir Cmax  16%
English: Pale orange coloured, oval shaped, chewable tablet scored on both sides with the MSD corporate logo and "477" on one side and without inscription on the other side.
Danish: Lys orange, oval tyggetablet med delekærv på begge sider, præget med MSD-virksomhedslogo og "477" på den ene side og ingen prægning på den anden side.
English: 25 mg chewable tablets: Each chewable tablet contains 25 mg of raltegravir (as potassium).
Danish: 25 mg tyggetabletter: Hver tyggetablet indeholder 25 mg raltegravir (som kalium).
English: 60 chewable tablets
Danish: 60 tyggetabletter
English: Uncommon acne, alopecia, dermatitis acneiforme, dry skin, erythema, facial wasting, hyperhidrosis, lipoatrophy, lipodystrophy acquired, lipohypertrophy, night sweats, prurigo, pruritus, pruritus generalised, rash macular, rash maculopapular, rash pruritic, skin lesion, urticaria, xeroderma, Stevens Johnson syndrome, drug rash with eosinophilia and systemic symptoms (DRESS)
Danish: Akne, alopeci, akneiform dermatitis, tør hud, erytem, tab af fedt i ansigtet, hyperhidrose, lipoatrofi, erhvervet lipodystrofi, lipohypertrofi, nattesved, prurigo, pruritus, generaliseret pruritus, makuløst udslæt, makulopapuløst udslæt, kløende udslæt, hudlæsioner, urticaria, xeroderma, StevensJohnsons syndrom, lægemiddeludslæt med eosinofili og systemiske symptomer (DRESS)
English: Percent HIV-RNA < 50 copies/mL (95 % CI) All patients
Danish: Procent hiv-RNA < 50 kopier/ml (95% CI) Alle patienter
English: Norelgestromin (raltegravir 400 mg Twice Daily)
Danish: Norelgestromin (raltegravir 400 mg to gange dagligt)
English: Isentress 25 mg chewable tablets Isentress 100 mg chewable tablets raltegravir
Danish: Isentress 25 mg tyggetabletter Isentress 100 mg tyggetabletter raltegravir
English: 100 mg chewable tablets: Each chewable tablet contains 100 mg of raltegravir (as potassium).
Danish: 100 mg tyggetabletter: Hver tyggetablet indeholder 100 mg raltegravir (som kalium).
English: ISENTRESS 100 mg granules for oral suspension
Danish: ISENTRESS 100 mg granulat til oral suspension
English: raltegravir AUC  72% raltegravir C24 hr  48% raltegravir Cmax  74%
Danish: raltegravir AUC  72% raltegravir C24t  48% raltegravir Cmax  74%
English: Raltegravir 600 mg (1,200 mg once daily)
Danish: Raltegravir 600 mg (1.200 mg en gang dagligt) (N = 531)
English: Co-administration of atazanavir with raltegravir 1,200 mg once daily significantly increased plasma levels of raltegravir; therefore, co-administration of raltegravir 1,200 mg once daily and atazanavir is not recommended.
Danish: Administration af atazanavir sammen med raltegravir 1.200 mg en gang dagligt øgede raltegravirs plasmakoncentration signifikant.
English: 1.5 x 100 mg † twice daily
Danish: 1,5 x 100 mg † to gange dagligt
English: OPIOID ANALGESICS methadone (raltegravir 400 mg Twice Daily)
Danish: OPIOIDANALGETIKA methadon (raltegravir 400 mg to gange dagligt)
English: You should check with your doctor, pharmacist or nurse if you are not sure.
Danish: Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget, du er i tvivl om.
English: If you take more Isentress than you should
Danish: Hvis du har taget for meget Isentress
English: Bottle for ISENTRESS 400 mg film-coated tablets
Danish: Flaske til ISENTRESS 400 mg - filmovertrukne tabletter
English: Baseline Characteristic HIV-RNA > 100,000 copies/mL
Danish: Alle patienter Karakteristika ved baseline Hiv-RNA > 100.000 kopier/ml ≤ 100.000 kopier/ml
English: Renal and urinary disorders Uncommon renal failure, nephritis, nephrolithiasis, nocturia, renal cyst, renal impairment, tubulointerstitial nephritis
Danish: Ikke almindelig Nyresvigt, nefritis, nefrolitiasis, nykturi, nyrecyste, nedsat nyrefunktion, tubulo-interstitiel nefritis
English: Table 5 displays pharmacokinetic parameters in the 400 mg tablet, the chewable tablet, and the granules for oral suspension, by body weight.
Danish: Tabel 5 viser de farmakokinetiske parametre for 400 mg tabletten, tyggetabletten og granulatet til oral suspension ud fra kropsvægt.
English: calcium carbonate antacid (raltegravir 400 mg Twice Daily)
Danish: antacidum med calciumcarbonat (raltegravir 400 mg to gange dagligt)
English: Number of chewable tablets
Danish: Antal tyggetabletter
English: 12 hours after raltegravir raltegravir AUC  14% raltegravir C24 hr  58% raltegravir Cmax  14%
Danish: 12 timer efter raltegravir raltegravir AUC  14% raltegravir C24t  58% raltegravir Cmax  14%
English: etravirine AUC  10 % etravirine C12hr  17 % etravirine Cmax  4 %
Danish: etravirin AUC  10% etravirin C12t  17% etravirin Cmax  4%
English: Uncommon erectile dysfunction, gynaecomastia, menopausal symptoms
Danish: Ikke almindelig Erektil dysfunktion, gynækomasti, menopausesymptomer
English: Isentress 100 mg granules for oral suspension raltegravir
Danish: ISENTRESS 100 mg granulat til oral suspension raltegravir
English: • abdominal pain upper; rectal discomfort; constipation; dry mouth; heartburn; pain when swallowing; inflammation of the pancreas; ulcer or sore in stomach or upper intestine; bleeding at anus; stomach discomfort; inflammation of the gums; swollen, red sore tongue
Danish: • Smerter i øverste del af maven, gener i endetarmen, forstoppelse, tør mund, halsbrand, synkesmerter, betændelse i bugspytkirtlen, sår eller ømhed i maven eller øvre del af mave-tarmkanalen, blødning ved endetarmen, mavegener, tandkødsbetændelse, hævet, rød, øm tunge
English: Recommendations concerning co-administration calcium carbonate antacid (raltegravir 1,200 mg single dose)
Danish: antacidum med calciumcarbonat (raltegravir 1.200 mg enkeltdosis)
English: - Hydroxypropyl cellulose - Sucralose - Mannitol - Monoammonium glycyrrhizinate - Sorbitol (E420) - Fructose - Banana flavour - Sucrose - Crospovidone, Type A - Magnesium stearate - Hypromellose 2910/6cP - Macrogol/PEG 400 - Ethylcellulose 20 cP - Ammonium hydroxide - Medium chain triglycerides - Oleic acid - Microcrystalline cellulose - Carmellose sodium
Danish: - Hydroxypropylcellulose - Sucralose - Mannitol - Monoammoniumglycyrrhizinat - Sorbitol (E420) - Fructose - Banansmag - Sucrose - Crospovidon, type A - Magnesiumstearat - Hypromellose 2910/6cP - Macrogol/PEG 400 - Ethylcellulose 20 cP - Ammoniumhydroxid - Triglycerider, middelkædelængde - Oliesyre - Mikrokrystallinsk cellulose - Carmellosenatrium
English: The treatment difference (raltegravir 1,200 mg once daily-raltegravir 400 mg twice daily) was 0.5 % with an associated 95 % CI of (-4.2, 5.2) establishing that raltegravir 1,200 mg once daily is non-inferior to raltegravir 400 mg twice daily.
Danish: Behandlingsdifferencen (raltegravir 1.200 mg en gang dagligt - raltegravir 400 mg to gange dagligt) var 0,5% med associeret 95% konfidensinterval (-4,2; 5,2), hvilket fastslog.
English: ISENTRESS 600 mg film-coated tablets
Danish: ISENTRESS 600 mg filmovertrukne tabletter
English: Carton for 100 mg chewable tablets
Danish: Karton til 100 mg tyggetabletter
English: Refer to the 400 mg and chewable tablet SmPCs for additional dosing information.
Danish: Se produktresuméerne for 400 mg tabletten og tyggetabletten for yderligere oplysninger om dosering.